These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21537837)

  • 21. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma.
    Roncalli M; Bosari S; Marchetti A; Buttitta F; Bossi P; Graziani D; Peracchia A; Bonavina L; Viale G; Coggi G
    Lab Invest; 1998 Sep; 78(9):1049-57. PubMed ID: 9759649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of the phosphorylation-independent recognition of cyclin D1 by the SCF
    Li Y; Jin K; Bunker E; Zhang X; Luo X; Liu X; Hao B
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):319-324. PubMed ID: 29279382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
    Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
    Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic alterations with impact on survival in esophageal squamous cell carcinoma identified by array comparative genomic hybridization.
    Shi ZZ; Liang JW; Zhan T; Wang BS; Lin DC; Liu SG; Hao JJ; Yang H; Zhang Y; Zhan QM; Zhang KT; Wang MR
    Genes Chromosomes Cancer; 2011 Jul; 50(7):518-26. PubMed ID: 21484929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
    Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
    Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
    Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S
    Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
    Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
    Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
    Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.
    Kurehara H; Ishiguro H; Kimura M; Mitsui A; Ando T; Sugito N; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
    Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects and mechanisms of FBXO31 on Taxol chemoresistance in esophageal squamous cell carcinoma.
    Lv L; Wang SC; Mo JY; Huang KL; Xu ML; Liu J
    Biochem Biophys Res Commun; 2022 Jan; 586():129-136. PubMed ID: 34839191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
    Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
    Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
    Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
    Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.
    Kumar R; Neilsen PM; Crawford J; McKirdy R; Lee J; Powell JA; Saif Z; Martin JM; Lombaerts M; Cornelisse CJ; Cleton-Jansen AM; Callen DF
    Cancer Res; 2005 Dec; 65(24):11304-13. PubMed ID: 16357137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.